comparemela.com

Latest Breaking News On - Harpoon therapeutics - Page 2 : comparemela.com

Is Johnson & Johnson Stock A Better Pick Over Merck?

Is Johnson & Johnson Stock A Better Pick Over Merck?
forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.

Samsung-bioepis
Acceleron-pharma
Health-care
Johnson
Amgen
Abiomed
Although-merck
Trefis-high-quality-portfolio
Cardiovascular-care
Medical-devices
Non-small-cell-lung-cancer
Prometheus-biosciences

Ono Pharmaceutical acquires Deciphera Pharmaceuticals for $2.4B

The $2.4 billion deal will bring Deciphera’s cancer drugs Qinlock, vimseltinib and DCC-3116 under Ono Pharmaceutical’s umbrella.

Massachusetts
United-states
Japan
Japanese
Gyo-sagara
Steven-hoerter
Ambrx-biopharma
Mono-group
Escient-pharmaceuticals
Drug-administration
Deciphera-pharmaceuticals
Ono-pharmaceutical

Merck raises 2024 profit forecast on cancer drug sales

Merck raises 2024 profit forecast on cancer drug sales
thefrontierpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thefrontierpost.com Daily Mail and Mail on Sunday newspapers.

China
Caroline-litchfield
Chris-schott
Merck-co-on
Drug-administration
Reuters
Chief-financial-officer-caroline-litchfield
Jersey-based-merck
Harpoon-therapeutics
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.